IDR Data
CMS PUF data · 2023 Q1–2025 Q4

Federal IDR outcomes: Intraoperative neuromonitoring in Pennsylvania

In 2025 Q1–Q4, the provider or facility offer prevailed in 86.7% of 9,393 determined Federal IDR dispute line items for intraoperative neuromonitoring in Pennsylvania. The median prevailing offer was 15.34x the QPA (25th–75th percentile 8.18x–27.17x; n = 8,097). The median time to a decision was 28 business days (n = 9,393).

Determined line items

9,393

2025 Q1–Q4 · 0 split decisions excluded

Provider win rate

86.7%

n = 9,393 · 2025 Q1–Q4

Median payment vs QPA

15.34x

middle half 8.18x–27.17x · n = 8,097 · 2025 Q1–Q4

Median days to decision

28

business days, from dispute initiation · n = 9,393 · 2025 Q1–Q4

Dollar amounts are not shown for specialty groups: the CMS QPA and Offers file, the only source of dollar figures, has no specialty field. See methodology.

By period

PeriodLine itemsWin %Median ×QPA25th–75thRatio nMedian days
2025 Q1–Q49,39386.7%15.34x8.18x–27.17x8,09728
2024 Q1–Q46,64789.6%12.22x7.65x–22.06x6,23945
2023 Q1–Q41,04883.4%11.77x4.36x–15.73x94742
2023 Q1–2025 Q417,08887.6%12.88x7.68x–24.02x15,283not pooled

Line items = determined dispute line items (n). Win rate excludes split decisions and includes default decisions. Ratio n = line items reporting a payment-to-QPA ratio. Days are business days as reported by CMS (2023–2024: from IDR entity assignment; 2025: from initiation) and are never pooled.

Most disputed CPT codes

CPT codeLine itemsWin %Median ×QPARatio nMedian days
95938 Placement of skin electrodes and measurement of stimulated sites on arms and leg2,71987.6%27.08x †2,42328
95939 Placement of skin electrodes and measurement of central motor stimulation in arm2,02988.1%13.10x1,94327
95941 Continuous remote monitoring of nervous system during operation, each hour1,64686.5%8.12x1,46027
95861 Needle measurement of electrical activity in arm or leg muscles, 2 extremities54085.7%10.31x39028
95870 Needle measurement of electrical activity in arm, leg, trunk or head muscles, li38884.5%7.65x34833.5
95937 Testing of nerve-muscle junction35483.3%18.70x20531
95940 Continuous monitoring of nervous system during operation, each 15 minutes27483.9%16.29x7337
95955 Measurement of brain wave activity (EEG) outside the brain during surgery16583.6%14.52x14727
95907 Nerve conduction, 1-2 studies10382.5%13.67x6033
95887 Needle measurement of electrical activity in trunk or head muscles5683.9%12.55x3032.5
95865 Needle measurement of electrical activity in voice box muscles5483.3%–2532
95886 Needle measurement of electrical activity in arm or leg muscles, complete study4285.7%41.60x †3924

2025 Q1–Q4 · rows with n ≥ 30 determined line items · sorted by n.

Related: all specialties in Pennsylvania · Intraoperative neuromonitoring in all states

FAQ

What is the Federal IDR provider win rate for intraoperative neuromonitoring in Pennsylvania?

In 2025 Q1–Q4, the provider or facility offer was selected in 86.7% of 9,393 determined dispute line items for intraoperative neuromonitoring in Pennsylvania. Split decisions are excluded from the denominator and default decisions are included. Withdrawn, settled and ineligible disputes are not in the CMS data.

How do Federal IDR payments compare with the QPA for intraoperative neuromonitoring in Pennsylvania?

In 2025 Q1–Q4, the median prevailing offer was 15.34x the qualifying payment amount (QPA), with a 25th to 75th percentile range of 8.18x to 27.17x (n = 8,097 line items). This uses the CMS field Prevailing Party Offer as % of QPA, where 1.00x equals the QPA.

How long do Federal IDR decisions take for intraoperative neuromonitoring in Pennsylvania?

In 2025 Q1–Q4, the median was 28 business days (n = 9,393 line items), using the CMS field Length of Time to Make Determination (from dispute initiation).

How to Utilize IDR